Mainz BioMed NV (MYNZ) Quote

mynz................................https://stockcharts.com/h-sc/ui?s=mynz&p=W&b=5&g=0&id=p86431144783

Thanks ...🥳...sold on a wash trade...https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175374580

Absorbing 30 million shares from offering dropped Oct 30th at .26 cents 

MYNZ...28...🥳...Psar flipped Bullish... https://schrts.co/DadDYwQx ..."W" in play here...

BERKELEY, Calif. and MAINZ, Germany, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced a collaborative agreement with Thermo Fisher Scientific Inc. (NYSE: TMO), through its subsidiary Life Technologies Corporation (“Thermo Fisher”), a world leader in supplying life sciences solutions and services.

The collaboration agreement will enable Mainz Biomed and Thermo Fisher to jointly develop and potentially commercialize Mainz Biomed’s Next Generation colorectal cancer screening product. The collaboration will harness Thermo Fisher’s powerful technologies, instrumentation and information translation systems to enable Mainz Biomed to develop the proprietary assays for its mRNA-based next-generation CRC screening tests which are redefining standards in early cancer detection. Mainz Biomed’s flagship non-invasive test not only targets the early detection of colorectal cancer but also focuses on precancerous lesions, particularly advanced adenomas, demonstrating significant clinical success in both US and European trials.

The collaboration will leverage combined capabilities to deliver testing solutions being developed at Mainz Biomed’s laboratories in Mainz, Germany.

Guido Baechler, CEO of Mainz Biomed, said: “This collaboration with Thermo Fisher will be instrumental to our goal to bring to market a home collection colorectal screening tool with highly effective detection of adenomas. Our product development will be greatly enhanced by Thermo Fisher’s knowledge and scalable, class-leading technologies, providing both partners with a means to accelerate the availability of an innovative new test for colorectal cancer screening around the world.”

Peter Jacobs, Director, EMEA Clinical Business Development, Thermo Fisher Scientific, said: “We are excited at the prospect of working with Mainz Biomed on their next generation screening test and are confident that together we will be able to achieve rapid progress and deliver innovative new assays for the global clinical marketplace.”

MYNZ........................https://stockcharts.com/h-sc/ui?s=MYNZ&p=W&b=5&g=0&id=p86431144783

Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today increasing demand from existing and prospective laboratory partners for its enhanced ColoAlert product that has been launched in July 2024 and is currently being commercialized across Europe and in select international markets. This advanced version of the Company’s colorectal cancer (CRC) screening test is set to become the standard offering for all existing partners, reflecting its proven benefits in optimizing screening efficiency and improving user experience.
Widespread Transition to Enhanced ColoAlert

One of the earliest partners to make the transition is GANZIMMUN Diagnostics, one of Germany’s premier laboratories, which licensed the ColoAlert test. GANZIMMUN will fully implement the enhanced version of the innovative DNA biomarker-based screening product by the beginning of next year, taking advantage of the significant improvements in sample processing and usability that have set a new industry benchmark.

Improving Customer Interest

Partners are particularly drawn to the enhanced features, such as the proprietary DNA stabilizing buffer that ensures reliable results despite varying sample volumes, and the streamlined collection devices that simplify at-home testing for users. These innovations have drastically reduced the need for retesting, offering faster turnaround times for patients, with results available in just 2–3 days from sample arrival.

Promotion at Key Medical Event

GANZIMMUN Diagnostics will showcase the enhanced ColoAlert at the 57th Medizinische Woche Baden-Baden, a medical congress in Germany focusing on complementary medicine, which takes place from October 30 to November 3, 2024. This underscores the increasing role of complementary medicine in cancer prevention and early detection. The event will provide an ideal platform to promote Mainz Biomed’s innovative DNA-based CRC screening test to medical professionals, integrative medicine practitioners, and researchers interested in advanced diagnostic solutions.
"We are excited to support GANZIMMUN in introducing the enhanced ColoAlert at such a prestigious event," stated Tarrin Khairi-Taraki, VP Commercial Operations at Mainz Biomed. "The 57th Medizinische Woche Baden-Baden provides an excellent opportunity to demonstrate the importance of early colorectal cancer detection and how our innovations are making this process more efficient."

Please visit Mainz Biomed’s official website for investors at mainzbiomed.com/investors/ for more information
Please follow us to stay up to date:
LinkedIn
X (Previously Twitter)
Facebook

MYNZ...3964...🥳

georgie18

Member Level
Re: georgie18 post# 655458

Friday, September 27, 2024 10:28:12 AM

Post#
659577
of 660763
MYNZ...245...Reversal Candle setting up here...🥳

georgie18

Member Level
Re: georgie18 post# 175

Wednesday, August 28, 2024 8:08:19 AM

Post#
181
of 199
MYNZ...39s clearing here...Off my .44 Alert...🥳

georgie18

Member Level
Re: georgie18 post# 655296

Monday, August 26, 2024 4:42:19 PM

Post#
655298
of 655457
MYNZ...44...on the 50MA Break...🥳

Spam and scam on social media - everywhere - bots and pumpers. Who is organizing that? No big volume still

MYNZ...245...Reversal Candle setting up here...🥳

georgie18

Member Level
Re: georgie18 post# 175

Wednesday, August 28, 2024 8:08:19 AM

Post#
181
of 199
MYNZ...39s clearing here...Off my .44 Alert...🥳

georgie18

Member Level
Re: georgie18 post# 655296

Monday, August 26, 2024 4:42:19 PM

Post#
655298
of 655457
MYNZ...44...on the 50MA Break...🥳

Last uptick?

MYNZ new 52 week low

Looks bad. No touch

Any news on this? FDA decision?

Waiting for news. Financials and fda response anyday imo

Is this stock losing traction? Where is the FDA approval?

Appears they got the FDA approval because the bleeding of the last few days has reversed. JMO

Obviously there will be a buyout with the FDA approval and a big run up. They always drive the pps down right before the run up to buy as cheap possible. Always some sort of manipulation going on. JMHO.

Obviously there will be a buyout with the FDA approval and a big run up. They always drive the pps down right before the run up to buy as cheap possible. Always some sort of manipulation going on. JMHO.

Dunno,shorts tearing into it today like a monkey eating a cupcake,shares to short went way up

Will the FDA approve?

Will be interesting AH
Approval or Not

Ready

Charting up,FDA news expected,

Bring on the fda news!

Little Fomo

Will the FDA approve…?

Chart lines soon crossing

MYNZ...39s clearing here...Off my .44 Alert...🥳

georgie18

Member Level
Re: georgie18 post# 655296

Monday, August 26, 2024 4:42:19 PM

Post#
655298
of 655457
MYNZ...44...on the 50MA Break...🥳

Loading zone, IMO .

Waiting on FDA decision

Not in a hurry !

Apparently no. Lol

Can we see so 50s today !

MYNZ...44...on the 50MA Break...🥳

45s looks like breakout on the way !

You welcome, still waiting on volume, I think after hours should be interesting, GL .

Ok thanks

https://x.com/henryv64655/status/1828098998106026378?s=46&t=SOfgYFcNY1OxgkraPxHd4g

Nice outlook

have you heard any projections on share price if the FDA approves?

42s up

Volume in !

Creeping up !

I’m not sure if that’s good or bad, maybe people loading, waiting on news, the last PR was about a month ago, and it’s moving on Friday, that’s what got my attention, hopefully we will get some news next week, it’s about time, IMO .

Quiet board

Coming off the 52WL, let’s see if we can get some attention, in for now !

Invest at your own risk!!!


https://stocktwits.com/BreakoutMaster8/message/583420341

MYNZ new 52 week low

https://x.com/ouma15/status/1821630173977977005?s=46

https://www.rttnews.com/3458713/mainz-biomed-seeks-fda-breakthrough-status-for-next-generation-crc-screening-test.aspx